Acquired Immunodeficiency (AID)
Showing 1 - 25 of 8,469
Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)
Available
- Epstein-Barr Virus (EBV) Infections
- +11 more
- tabelecleucel
- (no location specified)
Feb 15, 2022
HIV/AIDS Trial in Miami (Waitlist, Intervention)
Completed
- HIV/AIDS
- Waitlist
- Intervention
-
Miami, FloridaFlorida International University
Sep 14, 2021
Human Immunodeficiency Virus Infection, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)
Not yet recruiting
- Human Immunodeficiency Virus Infection
- +2 more
- Patient Participation Form
- (no location specified)
Mar 3, 2023
Gut Microbiome in People Living With HIV and HBV
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- (no location specified)
Nov 8, 2023
Acquired Brain Injury Trial in Glasgow, Paisley (ApplTree, Google Calendar)
Recruiting
- Acquired Brain Injury
- ApplTree
- Google Calendar
-
Glasgow, Dunbartonshire, United Kingdom
- +3 more
Oct 20, 2022
HIV Trial (Information, motivation, behavioral skills treatment arm, Information only control arm)
Not yet recruiting
- HIV
- Information, motivation, behavioral skills treatment arm
- Information only control arm
- (no location specified)
Oct 18, 2023
Chikungunya Virus Infection Trial (VLA1553)
Not yet recruiting
- Chikungunya Virus Infection
- VLA1553
- (no location specified)
Aug 31, 2023
HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)
Not yet recruiting
- HIV
- +2 more
- Prebiotic
- Probiotic
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 30, 2023
HIV, Aging Trial in Winston-Salem (Customized activity plan, Customized nutrition plan)
Not yet recruiting
- HIV
- Aging
- Customized activity plan
- Customized nutrition plan
-
Winston-Salem, North CarolinaAtrium Health Wake Forest Baptist
May 12, 2023
Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)
Recruiting
- Human Immunodeficiency Virus
- +2 more
-
Seattle, WashingtonUW Positve Research, Harborview Medical Center
May 8, 2023
Cancer in People Living With HIV/AIDS at Cancer Centers in Latin
Active, not recruiting
- HIV Infection
- +3 more
- Medical Chart Review
- Survey Administration
-
Buenos Aires, Argentina
- +3 more
Oct 20, 2022
Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco Trial in Boston, Chennai (Varenicline, Positively Smoke Free
Not yet recruiting
- Human Immunodeficiency Virus
- +2 more
- Varenicline
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 13, 2023
Alcohol Use Disorder, Human Immunodeficiency Virus Trial in Chicago (10 day prebiotic consumption)
Not yet recruiting
- Alcohol Use Disorder
- Human Immunodeficiency Virus
- 10 day prebiotic consumption
-
Chicago, IllinoisAli Keshavarzian
Nov 14, 2023
Human Immunodeficiency Virus Trial run by the CC (Placebo, Pembrolizumab)
Recruiting
- Human Immunodeficiency Virus
- Placebo
- Pembrolizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Human Immuno-deficiency Virus (HIV) Disease Trial (Budigalimab, Placebo for Budigalimab, ABBV-382)
Not yet recruiting
- Human Immuno-deficiency Virus (HIV) Disease
- Budigalimab
- +3 more
- (no location specified)
Sep 5, 2023
Transgender Health, Gender Dysphoria, Transgender Women Trial in Philadelphia (Doravirine/Lamivudine/Tenofovir, Spironolactone
Completed
- Transgender Health
- +3 more
- Doravirine/Lamivudine/Tenofovir
- +3 more
-
Philadelphia, PennsylvaniaClinical Research Unit at Thomas Jefferson University
Feb 1, 2023
HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)
Completed
- HIV-1-infection
- BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
-
Madrid, SpainHospital FUNDACIÓN JIMÉNEZ DÍAZ
Nov 2, 2022
Mycobacterium Abscessus Infection in Chronic Lung Disease and
Enrolling by invitation
- Mycobacterium Abscessus Infection
- +2 more
- Appropriate treatment
-
Pathum Wan, Bangkok, ThailandKing Chulalongkorn Memorial Hospital
Aug 31, 2022
Human Immunodeficiency Virus Trial in Chicago (brentuximab vedotin, Placebo, ART)
Recruiting
- Human Immunodeficiency Virus
- brentuximab vedotin
- +2 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
Jul 29, 2022
Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)
Not yet recruiting
- Human Immunodeficiency Virus
- HIV
- Islatravir
- Placebo
- (no location specified)
Oct 13, 2022
AIDS, Anemia, Hematologic Diseases Trial (erythropoietin, recombinant)
Completed
- Acquired Immunodeficiency Syndrome
- +4 more
- erythropoietin, recombinant
- (no location specified)
Nov 16, 2021